수의 진단 시장 : 제품 유형, 동물 유형, 검사 유형, 검체 유형, 기술, 질환 유형, 최종 사용자별 - 세계 시장 예측(2026-2032년)

The Veterinary Diagnostic Market is projected to grow by USD 6.59 billion at a CAGR of 7.79% by 2032.

Veterinary Diagnostic Market Introduction

Veterinary diagnostic solutions are becoming a core layer of modern animal health, spanning companion animal wellness, livestock productivity, food safety, zoonotic disease surveillance, and antimicrobial stewardship. The market includes reference laboratory testing, point-of-care analyzers, molecular diagnostics, immunodiagnostics, clinical chemistry, hematology, urinalysis, histopathology, microbiology, imaging-enabled diagnostics, and digital data platforms that support veterinarians in faster, more evidence-based decisions.

Demand is being reinforced by pet humanization, the rising prevalence of chronic and age-related conditions in companion animals, livestock disease management requirements, and global One Health priorities promoted by WHO, WOAH, FAO, and national veterinary authorities. As veterinary practices and producers move from reactive treatment to preventive care, diagnostic testing is increasingly positioned as a high-value clinical and operational investment rather than a discretionary expense.

Transformative Shifts in the Veterinary Diagnostic Landscape

The veterinary diagnostic landscape is shifting from centralized, episodic testing toward connected, rapid, and decentralized diagnostic workflows. Reference laboratories remain essential for complex panels, confirmatory testing, pathology, and high-throughput molecular assays, while in-clinic analyzers and point-of-care tests are expanding access to same-day results for wellness screening, infectious disease detection, and emergency care.

Molecular platforms, syndromic PCR panels, automated sample preparation, and digital laboratory information systems are improving turnaround times and standardization. At the same time, veterinary clinics, livestock operators, and public health agencies are demanding stronger data interoperability, traceability, quality management, and compliance with evolving regulatory expectations. These shifts are creating opportunities for organizations that combine validated assays, workflow automation, service reliability, and actionable clinical interpretation.

Cumulative Impact of Artificial Intelligence on Veterinary Diagnostics

Artificial intelligence is beginning to reshape veterinary diagnostics by enhancing image interpretation, laboratory triage, cytology and pathology review, radiology support, pattern recognition in laboratory data, and predictive surveillance for infectious disease risk. AI-enabled decision support can help veterinarians prioritize abnormal results, identify clinically relevant trends, and connect diagnostic findings with treatment pathways more efficiently.

The cumulative impact of AI is strongest when algorithms are validated against high-quality veterinary datasets and embedded into clinician-controlled workflows. Industry adoption depends on transparency, explainability, cybersecurity, data governance, and compliance with veterinary practice standards. AI is not replacing veterinary judgment; it is improving speed, consistency, and scalability in diagnostic interpretation where evidence, quality assurance, and clinical oversight are maintained.

Key Regional Insights for Veterinary Diagnostics

Asia-Pacific is one of the most dynamic veterinary diagnostic regions, supported by expanding companion animal ownership, intensive livestock production, and government attention to transboundary animal disease control. China, India, Japan, South Korea, and Australia are investing in diagnostic capacity for food security, export quality, and pet healthcare, while Southeast Asian markets are improving access to molecular and immunodiagnostic testing as animal health systems respond to avian influenza, African swine fever, rabies, and antimicrobial resistance priorities.

North America benefits from advanced veterinary infrastructure, high pet healthcare spending, large reference laboratory networks, and strong adoption of in-clinic diagnostics. Europe is shaped by rigorous animal health regulation, antimicrobial stewardship policies, food chain surveillance, and high standards for laboratory quality under coordinated public health and animal health frameworks. Latin America is gaining momentum through livestock disease monitoring, companion animal care growth, export-oriented meat production, and the need for scalable diagnostics across geographically diverse markets.

The Middle East is expanding veterinary diagnostic demand through food security programs, equine and camel health, livestock management, and premium companion animal care in urban centers. Africa presents long-term opportunities tied to zoonotic disease surveillance, livestock health, and international development programs, with diagnostic priorities influenced by diseases such as rabies, brucellosis, Rift Valley fever, and peste des petits ruminants, although access, affordability, cold-chain logistics, and laboratory infrastructure remain important adoption constraints.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is linked to livestock biosecurity, aquaculture health, companion animal growth, and regional efforts to manage zoonotic and transboundary diseases. Markets across the bloc are gradually upgrading laboratory infrastructure and point-of-care access, with adoption influenced by affordability, distributor networks, and veterinary workforce capacity. The GCC is characterized by strong demand for diagnostics in companion animals, equine medicine, camel health, and food security initiatives, supported by higher purchasing power, expanding specialty veterinary services, and government-backed animal health modernization.

The European Union remains a benchmark for regulated veterinary diagnostics, driven by animal health law, food safety oversight, antimicrobial resistance monitoring, and cross-border disease surveillance. BRICS countries combine large livestock populations, fast-growing pet care sectors, and public health priorities, creating demand for cost-effective, scalable, and locally adaptable diagnostic platforms. G7 markets lead in premium diagnostics, digital integration, advanced laboratory services, and evidence-based companion animal care, while NATO countries benefit from coordinated biosecurity priorities, supply chain resilience planning, and surveillance systems relevant to animal and public health readiness.

Key Country Insights in Veterinary Diagnostics

The United States leads in veterinary diagnostic innovation through high companion animal spending, large reference lab networks, advanced point-of-care adoption, and strong specialty veterinary care. Canada shows steady demand supported by preventive pet care, livestock surveillance, and public health alignment, while Mexico is expanding diagnostic access for companion animals and production animals through private clinics and livestock health programs. Brazil is a major veterinary diagnostic market due to its large cattle, poultry, and swine industries, alongside a growing pet healthcare sector and strong requirements for herd health, export assurance, and food safety testing.

In Europe, the United Kingdom, Germany, France, Italy, and Spain demonstrate strong adoption of companion animal diagnostics, antimicrobial stewardship, and laboratory quality systems. Germany and France remain important centers for animal health research and regulated testing, while Italy and Spain combine pet care expansion with livestock and food safety needs. Russia maintains demand across livestock disease management and urban companion animal care, with procurement and technology access shaped by local regulatory and supply conditions.

China is scaling veterinary diagnostic capacity for livestock biosecurity, pet care, and food safety, supported by heightened attention to swine, poultry, dairy, and zoonotic disease surveillance. India's growth is tied to dairy, poultry, companion animal clinics, and disease surveillance needs, with diagnostic access expanding through urban veterinary services and public livestock health programs. Japan and South Korea are advanced companion animal markets with high expectations for precision, automation, and quality, while Australia emphasizes biosecurity, livestock export assurance, companion animal wellness, and surveillance programs that protect its disease status and agricultural trade position.

Actionable Recommendations for Veterinary Diagnostic Industry Leaders

Industry leaders should prioritize integrated diagnostic ecosystems that combine validated assays, analyzers, software, logistics, and clinical interpretation. Organizations that reduce turnaround time while improving accuracy, workflow efficiency, and veterinarian confidence are best positioned to capture demand across both companion animal and livestock settings.

Strategic investment should focus on molecular panels for infectious disease, scalable point-of-care platforms, AI-assisted interpretation, cloud-connected laboratory systems, and quality assurance programs. Partnerships with veterinary clinics, universities, livestock producers, public health agencies, and distributors can accelerate market access. Leaders should also design tiered product portfolios for both premium and cost-sensitive markets, strengthen reagent supply resilience, expand training programs, and support data interoperability that improves diagnostic utilization, compliance, and One Health surveillance value.

Research Methodology

This executive summary is developed using a structured market research approach that integrates verified secondary research, regulatory review, product portfolio assessment, clinical guideline evaluation, and analysis of regional animal health priorities. Sources considered include veterinary associations, public health agencies, animal health authorities, peer-reviewed literature, regulatory publications, disease surveillance updates, and recognized One Health frameworks.

The methodology emphasizes triangulation across demand drivers, technology adoption, regional infrastructure, disease surveillance priorities, and competitive positioning. Qualitative insights are assessed alongside observable market indicators such as diagnostic workflow modernization, reference laboratory expansion, point-of-care adoption, veterinary service utilization, livestock biosecurity investment, antimicrobial resistance monitoring, and the integration of digital and AI-enabled tools.

Conclusion

Veterinary diagnostics are moving to the center of preventive, precision, and population-level animal healthcare. The sector is benefiting from rising companion animal medicalization, livestock productivity requirements, food safety mandates, zoonotic disease vigilance, antimicrobial stewardship, and the operational need for faster, more reliable clinical answers.

Future industry leadership will depend on the ability to deliver accurate tests, connected platforms, strong service models, and evidence-based interpretation across diverse regional needs. Organizations that align innovation with One Health priorities, affordability, regulatory compliance, and veterinarian-centered workflows will be best positioned to shape the next phase of veterinary diagnostic growth.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Diagnostic Market, by Product Type

• 7.1. Instruments
  • 7.1.1. Chemistry Analyzers
  • 7.1.2. Hematology Analyzers
  • 7.1.3. Microscopy Systems
  • 7.1.4. PCR Instruments
• 7.2. Reagents
• 7.3. Software & Services
  • 7.3.1. Consulting Services
  • 7.3.2. Data Management Software
  • 7.3.3. Training Services

8. Veterinary Diagnostic Market, by Animal Type

• 8.1. Aquaculture
• 8.2. Companion Animals
• 8.3. Equine
• 8.4. Livestock
• 8.5. Poultry

9. Veterinary Diagnostic Market, by Test Type

• 9.1. Clinical Biochemistry
• 9.2. Hematology
• 9.3. Imaging
• 9.4. Immunodiagnostics
• 9.5. Microbiology
• 9.6. Molecular Diagnostics

10. Veterinary Diagnostic Market, by Sample Type

• 10.1. Serum & Plasma
• 10.2. Tissue
• 10.3. Urine
• 10.4. Whole Blood

11. Veterinary Diagnostic Market, by Technology

• 11.1. Flow Cytometry
• 11.2. Immunoassays
• 11.3. Next-Generation Sequencing
• 11.4. Polymerase Chain Reaction (PCR)

12. Veterinary Diagnostic Market, by Disease Type

• 12.1. Genetic Disorders
• 12.2. Infectious Diseases
  • 12.2.1. Bacterial
  • 12.2.2. Fungal
  • 12.2.3. Parasitic
  • 12.2.4. Viral
• 12.3. Metabolic Disorders
• 12.4. Neoplastic Disorders

13. Veterinary Diagnostic Market, by End User

• 13.1. Academic & Research Institutes
• 13.2. Diagnostic Laboratories
• 13.3. Point Of Care Testing
• 13.4. Veterinary Hospitals

14. Veterinary Diagnostic Market, by Region

• 14.1. Asia-Pacific
• 14.2. North America
• 14.3. Latin America
• 14.4. Europe
• 14.5. Middle East
• 14.6. Africa

15. Veterinary Diagnostic Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Veterinary Diagnostic Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025

18. Company Profiles

• 18.1. Agrolabo S.p.A.
• 18.2. Bio-Rad Laboratories, Inc.
• 18.3. Biogal Galed Labs
• 18.4. BioMerieux S.A.
• 18.5. BioNote USA, Inc.
• 18.6. Demeditec Diagnostics GmbH
• 18.7. Eurofins Scientific SE
• 18.8. Fassisi GmbH
• 18.9. FUJIFILM Holdings Corporation
• 18.10. IDEXX Laboratories, Inc.
• 18.11. Mars, Incorporated
• 18.12. Meridian Bioscience, Inc.
• 18.13. Neogen Corporation
• 18.14. Promega Corporation
• 18.15. QIAGEN N.V.
• 18.16. Randox Laboratories, Ltd.
• 18.17. SAN Group Biotech Germany GmbH
• 18.18. Shenzhen Mindray Animal Medical Technology Co., Ltd.
• 18.19. Thermo Fisher Scientific Inc.
• 18.20. Vimian Group AB
• 18.21. Virbac S.A.
• 18.22. Zoetis Inc.